Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature 454, 160-161 (10 July 2008) | doi:10.1038/454160a; Published online 9 July 2008
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Gastroenterologist
- South Atlanta Medical Clinic, PC (GI Group)
- Atlanta, GA, USA
Manager-SCI
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
The contents of the syringe
Steven Salzberg1
- Steven Salzberg is at the Center for Bioinformatics and Computational Biology, 3125 Biomolecular Sciences Building, University of Maryland, College Park, Maryland 20742.
Abstract
The influenza vaccine failed this winter. Steven Salzberg suggests that future success relies on sharing data more widely and making the virus strain selection process more transparent.
During the past 50 years, the scientific community has studied the influenza virus in great detail, and has developed an effective vaccine that is administered widely each year. The vaccine contains isolates from each of the three strains commonly circulating in humans: H3N2, H1N1 and influenza B.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Know the enemyNature Biotechnology News and Views (01 Mar 2006)
Lessons from the 1918 influenzaNature Biotechnology News and Views (01 Apr 2007)
See all 3 matches for News And Views